Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-10-30

FDA Approved: CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE — Original Application (Glenmark Pharmaceuticals Inc. USA)

View source ↗

Summary

FDA approved Glenmark's generic topical combination of clotrimazole and betamethasone dipropionate (ANDA 202894). It is indicated for inflammatory fungal skin i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clotrimazole and betamethasone dipropionate (clotrimazole and betamethasone dipropionate)

Snippet

ORIG AP for CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE (CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE)